Patents by Inventor Richard David Perrins

Richard David Perrins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • REVERSE PEPTIDES FROM CORONAVIRUS FOR IMMUNOGENIC PURPOSES
    Publication number: 20250101065
    Abstract: The invention relates to immunogenic peptides encoded by an open reading frame (ORF) encoded by at least part of the genome of a coronavirus in the opposite sense to positive sense RNA capable of translation. The invention also relates to polynucleotides encoding such peptide, the use of such peptides and polynucleotides for the treatment and prevention of viral infection, and complexes comprising the peptides of the invention.
    Type: Application
    Filed: February 16, 2022
    Publication date: March 27, 2025
    Inventors: Thomas Rademacher, Xiaofang Huang, Richard David Perrins, Nicole Bedke, Athanasios Papadopoulos, Phillip Williams
  • Reverse peptide vaccine
    Patent number: 12156909
    Abstract: The invention relates to vaccine compositions comprising peptides encoded by an open reading frame (ORF) encoded by at least part of the genome of a ssRNA virus in the opposite sense to positive sense RNA capable of translation, and the use of such compositions for the treatment and prevention of viral infection.
    Type: Grant
    Filed: May 20, 2019
    Date of Patent: December 3, 2024
    Assignee: Emergex Vaccines Holding Limited
    Inventors: Ramila Philip, Richard David Perrins, Xiaofang Huang, Thomas Rademacher, Christopher Upton
  • REVERSE PEPTIDE VACCINE
    Publication number: 20210299241
    Abstract: The invention relates to vaccine compositions comprising peptides encoded by an open reading frame (ORF) encoded by at least part of the genome of a ssRNA virus in the opposite sense to positive sense RNA capable of translation, and the use of such compositions for the treatment and prevention of viral infection.
    Type: Application
    Filed: May 20, 2019
    Publication date: September 30, 2021
    Inventors: Ramila Philip, Richard David Perrins, Xiaofang Huang, Thomas Rademacher, Christopher Upton